Life Science Talent Talks

In this special edition of Life Science Talent Talks, Nehar sat down with Mads Terndrup, the founder of Exo360, a groundbreaking startup focused on transforming non-surgical treatment options for fractures. This episode is part of a collaboration with TechBBQ 2024, where Exo360 will pitch on the Life Science Without Borders stage. Mads shares his journey from a promising career in orthopedic surgery to founding Exo360, a company that aims to replace outdated plaster casting methods with innovative, standardized solutions using metamaterials. The discussion covers the challenges of merging clinical expertise with entrepreneurial ambition, the development of their first product—the XO360 wrist—and their plans to address diabetic foot ulcers. Timestamps: 01:14 Meet Mads, founder of Exo360 01:57 The Problem Exo360 is Solving 03:00 The transition from an orthopedic surgeon to an entrepreneur. 03:53 Mads persuaded Michael, a branding and marketing expert, to join Exo360 04:48 Exo360’s First Product 06:48 Discussion on the challenges of developing a medical device. 09:00 Launching a new funding round to accelerate the development of a solution for diabetic foot ulcers. Ideas for future podcast guests or themes? 💡 We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes. Feel free to share in a private message or leave a comment below 🙏🏼 (It's also ok to invite yourself 😉) Join Our Life Science Talent Ecosystem We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

In this episode, Peter Holme, the CEO of Cambiotics, discusses his new startup, a spinoff from the University of Cambridge aimed at detoxifying the human body from harmful PFAS chemicals using precision probiotics. Peter shares his extensive background as a scientist and entrepreneur, including his journey with Aquapoint and his involvement in innovation in Denmark. He explains the science behind Cambiotics, the current stage of the company, and the challenges they face in transitioning from lab and animal studies to human clinical trials. Peter highlights their plan to introduce the product to the U.S. market by partnering with the American Firefighter Associations, who are at high risk of PFAS exposure. He also discusses the company's participation in TechBBQ and emphasizes the critical need for global awareness about PFAS pollution. Timestamps: 00:00 Introduction to Peter Holme and Cambiotics 01:58 Overview of Cambiotics 02:34 Technology Behind Cambiotics 03:21 Current Stage and Future Plans 04:02 Challenges and Clinical Trials 06:56 Participation in Tech Barbecue 08:07 Raising Awareness About PFAS 09:58 Conclusion and Final Thoughts Ideas for future podcast guests or themes? 💡 We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes. Feel free to share in a private message or leave a comment below 🙏🏼 (It's also ok to invite yourself 😉) Join Our Life Science Talent Ecosystem We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

In this episode, Shannon and Kathryn, co-founders of Reefcircular, discuss their innovative startup that develops environmentally friendly bioconcrete made from waste shells, which is 3D printed into artificial reefs. They share their backgrounds in marine science and architecture, recount the serendipitous way they met, and describe their research and development phase, including their first pilot project in Denmark. They highlight the need for boosting biodiversity and fish stocks in temperate climates, their unique reef designs, and the challenges of funding and market awareness. They also talk about their participation in TechBBQ 2024 and invite collaborations to further their mission. Timestamps: 00:00 Meet the Founders: Shannon and Kathryn 01:49 The Birth of Reefcircular 01:56 Innovative Bioconcrete and 3D Printing 02:33 A Chance Meeting on Facebook 03:10 Current Stage and Pilot Projects 03:55 First Deployment Success 04:28 Designing and Installing Boulder Reefs 05:42 Boosting Biodiversity and Fish Stocks 07:41 Challenges and Market Potential 09:10 Tech Barbecue 2024 Participation 10:05 Call to Action and Future Collaborations Ideas for future podcast guests or themes? 💡 We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes. Feel free to share in a private message or leave a comment below 🙏🏼 (It's also ok to invite yourself 😉) Join Our Life Science Talent Ecosystem We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

In this episode of Life Science Talent Talks, host Nehar Mortuza sits down with Rahmad Akbar, Senior Data Scientist in Antibody Design at Novo Nordisk. Rahmad shares his remarkable journey from his roots in Indonesia to his pivotal role at the forefront of machine learning-driven protein engineering. Together, they explore how AI is revolutionising antibody design — from the technical advances and current challenges to the growing role of generative models in creating next-generation therapeutics. Rahmad offers insights into how these technologies are accelerating drug discovery, improving patient outcomes, and shaping the future of healthcare. He also speaks candidly about his transition from academia to industry, the personal motivations that fuel his work, and why collaboration and innovation are more essential than ever in the life sciences. Whether you're passionate about biotech, data science, or career development, this episode is packed with valuable perspectives you won't want to miss.Timestamp and Show notes:00:38 Meet Our Special Guest: Rahmad Akbar02:19 Rahmad's Journey: From Indonesia to Novo Nordisk03:35 The Role of Coding in Biotechnology04:45 Antibody Design: Challenges and Innovations06:48 Generative AI in Drug Design10:04 Future Trends and Democratizing AI19:00 Personal Motivations and Career Reflections24:31 Transitioning from Academia to Industry29:47 Final Thoughts and TakeawaysIdeas for future podcast guests or themes? 💡We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.Join Our Life Science Talent EcosystemWe want to build a community to inspire life science professionals and leaders through talent talks and organised events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

In this episode, we take you inside the story of Mmimetika, a biotech venture co-founded by researchers Mogens Johannsen and Thomas Poulsen. What began as a bold university lab project has grown into a breakthrough company developing a compound that mimics some of the key health benefits of exercise and fasting. By combining ketones and lactate in a single, novel molecule, Mmimetika's lactate | ketone non-medicinal supplement provides promising support for metabolic control and longevity. We dive into their journey from academic discovery to commercial reality — securing patents, scaling production, attracting investors, and building a business team around their scientific vision.Now on the cusp of regulatory approval, Mmimetika is actively searching for a dynamic CEO to lead the charge into market launch and long-term growth.Whether you're curious about biotech entrepreneurship, metabolic health innovations, or how groundbreaking research turns into real-world solutions, this is a story you won’t want to miss.Shownotes and Timestamps[00:00:00] Company Introduction  [00:01:12] Mimicking Exercise and Fasting  [00:04:08] Current Status and Journey  [00:05:54] Product Superiority and Development  [00:08:13] Competition and IP  [00:10:18] Funding and Investor Relations  [00:11:17] Technical Aspects of the Product  [00:13:00] Clinical Evidence and Scientific Approach  [00:14:22] Non-Medical Claims[00:15:29] Market Focus and Positioning  [00:17:58] Roadmap and Milestones  [00:21:22] Organizational Structure and Key Risks  [00:23:00] CEO Transition and Future Roles  [00:25:04] Company Culture and CEO Profile  [00:27:26] Soft Skills and Ideal Timing for CEO  [00:29:42] How Listeners Can Support  Ideas for future podcast guests or themes? 💡We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.Feel free to share in a private message or leave a comment below 🙏🏼(It's also ok to invite yourself 😉)Join Our Life Science Talent EcosystemWe want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

In this episode, we sit down with Janine Erler, CEO, and Lluís Riera Ponsati, Program Lead at NEUmiRNA Therapeutics to discuss their groundbreaking work in developing disease-modifying RNA therapies for neurological disorders. From their startup journey to the intricate science behind their therapies, the conversation spans key milestones, technology challenges, and the unique patient-focused culture at Neumirna. Janine and Lluís share insights on their successful fundraising, the impact of their microRNA-based approach, and the practical aspects of going from academic research to clinical applications. They also discuss the organizational dynamics, collaborations, and future aspirations of the company, making this a compelling listen for any life sciences professional interested in the transformative potential of RNA therapies.Show notes & Timestamp00:43 Introducing Neumirna Therapeutics02:10 Founding Story of Neumirna03:29 Key Milestones and Team Growth06:50 Challenges and Collaborations15:23 Technology Behind Neumirna's RNA Therapies23:19 Focus on Neurological Diseases24:57 Exploring the Potential of ASO Technology25:26 The Future of RNA Therapies27:44 Navigating Regulatory Challenges28:37 Team and Culture at Neumirna35:23 Hiring and Onboarding at Neumirna37:36 Proud Moments and Achievements43:02 Immediate Priorities and Challenges44:43 Connecting with the Community45:51 Conclusion and Final ThoughtsIdeas for future podcast guests or themes? 💡We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.Feel free to share in a private message or leave a comment below 🙏🏼(It's also ok to invite yourself 😉)Join Our Life Science Talent EcosystemWe want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

In this episode, Susanne Gløersen, founder of The Future of Fungi Award and Fungi Investment Collective, discusses her mission to build a global ecosystem fueled by fungi innovation. The conversation covers the multifaceted applications of fungi, from food and materials to packaging and environmental remediation.Susanne shares the origins of her passion for fungi, the purpose and success of the Future Fungi Award, and the criteria for selecting award winners and investment opportunities. She emphasizes the role of fungi in addressing pressing environmental issues and the importance of collaboration and community in advancing fungi innovation. Additionally, Susanne dives into the workings of the Fungi Investment Collective, highlighting how it supports pioneering scientists and startups with funding and resources. Essential for anyone interested in sustainable innovation, this episode unveils the transformative potential of fungi and how it can drive us towards a more balanced and nature-cooperative economy.Shownotes and Timestamps00:55 Introduction and Overview of Fungi Innovation01:55 Susanne's Background and Journey into Fungi04:48 Mission and Vision for Fungi Innovation06:38 The Future Fungi Award08:07 Highlighting Award Winners and Their Innovations15:06 Support and Collaboration Opportunities19:22 Introduction to the Fungi Investment Collective24:46 Building a Network of Science Venture Partners25:30 Investment Priorities and Criteria26:54 Funding Ranges and Case Dependency27:54 Connecting with the Fungi Investment Collective28:55 Opportunities for Aspiring Venture Partners32:33 Proud Accomplishments and Network Effects36:27 Challenges and Learnings as a First-Time Entrepreneur41:12 Future of Fungi Innovation and Exciting Startups46:33 Conclusion and Call to Join the MovementResources Mentioned:Awards, Collectives, and Initiatives- Fungi Investment Collective- Venture Builder Pilot Program (for top scientists)- The Mycelium Network (community concept)Podcasts & Media- The Future is Fungi PodcastNotable Startups & Projects- Jens Laurids Sørensen (battery out of fungi)- Nova Biome (textile waste to bioactive compounds for cosmetics, in L'Oreal's accelerator)- Line Kloster Pedersen, Visibuilt (Danish startup making mycelium binder for asphalt production)- William Newell, Electromicrobial CO2 fixation project (Imperial College of London)- Nomy (Norwegian Mycelium, feed for aquaculture)- Michael Lever (German company, surfactants from fungi)Conferences & Events- ChangeNow (largest accessibility conference)- IMC12 (International Mycology Congress)- Brilliant Minds (an event where Obama and Malala have spoken)Corporates & Partners- L'Oreal (accelerator)- Novo Holdings (jury pre-screening)- SEB (Green Tech VC, large Nordic Bank)Book Recommendations-Entangled Life by Merlin SheldrakeOther- LinkedIn (The Fungi Investment Collective)- Fungi Investment Collective website/contact form- Email: Suzanne@fungiinvestmentcollective.comIdeas for future podcast guests or themes? 💡We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.Feel free to share in a private message or leave a comment below 🙏🏼(It's also ok to invite yourself 😉)Join Our Life Science Talent EcosystemWe want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

In this episode of Life Science Talent Talks, Nehar Mortuza looks into the dynamic world of life sciences with special guest Mikkel Skovborg, Vice President at the Novo Nordisk Foundation. Mikkel shares his journey from academia to industry and discusses the foundation’s mission to foster innovation, entrepreneurship, and scientific research. He highlights key initiatives like the Bio Innovation Institute (BII) and public-private partnerships that aim to enhance the life science ecosystem in Denmark and beyond. The conversation covers the impact of regulatory challenges, the promise of emerging technologies such as quantum computing and gene cell therapy, and the importance of global talent and collaborations. Mikkel also provides insights on the evolving landscape of life sciences, offering advice to aspiring professionals and reflecting on the lessons learned throughout his career.Timestamps:00:45 | Introducing Our Guest – Mikkel Skovborg01:36 | Career Journey & Influences – From Academia to Industry04:15 | The Mission & Impact of the Novo Nordisk Foundation07:22 | Challenges & Opportunities in the Life Science Sector14:03 | Denmark’s Role as a Hub for Startups & Talent16:19 | Personal Insights & Reflections from Mikkel Skovborg19:20 | Conclusion & Key TakeawaysIdeas for future podcast guests or themes? 💡We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.Feel free to share in a private message or leave a comment below 🙏🏼(It's also ok to invite yourself 😉)Join Our Life Science Talent EcosystemWe want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

Guests: Susanne Palsten Buchardt (Incoming CEO) & Henrik Busch‑Larsen (Founder, former CEO at Algiecel)Episode in a TweetWhen a founder steps aside, how do you keep the vision alive? Hear how Algiecel is turning a CEO hand‑over into rocket fuel for growth — while scaling microalgae tech that captures CO₂ and feeds the world.What You’ll LearnHow Algiecel’s photo‑bioreactor technology converts industrial CO₂ into high‑value microalgae ingredients.The behind‑the‑scenes playbook for planning a smooth CEO succession.Why trust, transparent communication, and role clarity made the hand‑over a win‑win.Susanne’s journey from strategy consultant to CCO to CEO—and Henrik’s new focus on partnerships & investment.Actionable advice for founders preparing their own succession road‑map.00:00 Intro – Welcome & episode set‑up02:04 Algiecel’s Mission & Tech – Microalgae, CO₂ utilisation, and photo‑bioreactors04:45 Origin Story – Henrik’s eco‑vision and the company’s early pivots09:08 Why Succession & Why Now? – Spotting the right moment for change12:56 From CCO to CEO – Susanne’s growth path and leadership style16:05 Building the Dream Team – Diversity, healthy debate, and shared values 21:10 Board & Investor Alignment – Governance during leadership change 22:40 Redefining Roles – Henrik’s shift to partnerships & thought leadership 25:02 Stakeholder Communications – Keeping customers & partners in the loop30:12 Founders’ Advice – Mentorship, self‑awareness, and planning ahead36:47 Future Road‑map – Scaling tech, funding, and global impact38:50 Lightning Round & Wrap‑up – Quick takes and final thoughtsResource Mentioned:Unibio – Single‑cell protein pioneers BioInnovation Institute (BII) – Life‑science venture labIdeas for future podcast guests or themes? 💡We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.Feel free to share in a private message or leave a comment below 🙏🏼(It's also ok to invite yourself 😉)Join Our Life Science Talent EcosystemWe want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

In this episode of Life Science Talent Talks, Thomas Kirkegaard Jensen, CEO of Amplify Therapeutics and a seasoned entrepreneur in the life science startup world, joins Søren for an in-depth conversation about building healthy company culture in high-pressure environments. Drawing on over 15 years of experience—including his pivotal role at Orphazyme, where he contributed to the development and FDA approval of a groundbreaking rare disease treatment (now part of Zevra Therapeutics through acquisition)The discussion explores how to foster trust-based, high-performance cultures, with a focus on psychological safety, clear communication, competence mapping, and managing the organizational challenges that come with growth. Thomas reflects on his leadership style, the importance of understanding personal strengths and blind spots, and the tools and systems he uses to shape team culture intentionally. Thomas shares practical insights on when to begin deliberately cultivating culture, how Amplify Therapeutics approaches team dynamics, and the key lessons he’s learned from leading in both startup and scale-up phases.The conversation also touches on milestones in team development and R&D, and Thomas’s vision for the company’s future. This episode is especially relevant for startup leaders and life science professionals interested in entrepreneurship, innovation, and building strong, sustainable teams in complex, high-stakes environments.Timestamp and Shownotes:00:43 – Thomas’s Journey in Biotech02:04 – Deep Dive into Amplify Therapeutics06:53 – The Birth of Amplify Therapeutics16:40 – Building a Healthy Startup Culture34:23 – Specialization and Responsibility Shifts35:33 – Leadership and Organizational Growth38:05 – Competence Mapping and Skills Assessment39:33 – Trust and Communication in Teams45:22 – Balancing Fast Decisions with Thoughtfulness52:28 – Reflections on Achievements and Culture55:18 – Advice for First-Time CEOs56:43 – Future Challenges and Opportunities58:15 – Support and Career Opportunities01:02:39 – The Reality of Working in BiotechIdeas for future podcast guests or themes? 💡We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.Feel free to share in a private message or leave a comment below 🙏🏼(It's also ok to invite yourself 😉)Join Our Life Science Talent EcosystemWe want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

15 min teaser episode. Listen to the full episode in EP56 (Full).Today we're diving into a biotech story that should be on every venture capitalist’s radar: Amplify Therapeutics. This is a company that’s shaking up drug development for neurodegenerative diseases—think ALS, Parkinson’s, frontotemporal dementia—not by throwing money at the problem, but by building smarter, faster, and more efficiently.Founded by Thomas Kirkegaard Jensen—yes, the same scientific mind behind the legacy of Orphazyme—Amplify is zeroing in on lysosomal function and proteostasis, two mechanisms that hold huge promise across multiple disease areas. But here’s the kicker: they’re doing it lean. They’ve built a capital-efficient model, using validated targets and real-world biomarkers to reduce risk and speed up timelines.This isn’t a moonshot—it’s a well-designed, data-driven platform with serious scalability. And with their first program heading into the clinic, Amplify is already primed for partnerships, licensing deals, and smart funding. Add a leadership team with deep regulatory experience and a proven track record of exits, and you’ve got a company that’s not just ready for the next phase—it’s ready to lead.For VCs looking for high-impact biotech with serious upside, this is one worth watching. Stay tuned—Amplify is just getting started.Timestamp and Shownotes:00:00:41 – Thomas shares his entry into biotech via Orphazyme00:02:00 – Thomas emphasizes the importance of trust-based and healthy team culture for high-performance in biotech environments.00:02:09 – Thomas explains Amplify’s mission: to develop medicines for genetically defined neurodegenerative diseases by targeting lysosomal biology.00:03:00 – Discussion on whether Amplify is a platform-based company or asset-driven. Thomas describes their diversified small-molecule approach grounded in deep lysosomal expertise.00:04:00 – Thomas shares how he reacquired assets from Zevra after Orphazyme's dissolution and spun them into a new company, Amplify Therapeutics.00:06:00 – Licensing + Foundation of Amplify00:06:33 – Thomas outlines how he secured a startup grant from BioInnovation Institute (BII) in Copenhagen while finalizing the licensing deal.00:07:51 – Early Team Building00:08:33 – Thomas discusses balancing speed, flexibility, and internal know-how through selective in-house work.00:09:41 – Thomas explains their hybrid approach: outsourcing standard assays, while keeping complex, specialized biology assays in-house for better agility and knowledge retention.00:11:12 – Current Pipeline Overview Amplify’s portfolio includes three projects:Lead program with multiple chemistriesOxford University collaborationPotential Danish Cancer Society program00:12:14 – Amplify is preparing for a fundraising round to scale operations and advance pipeline developmentIdeas for future podcast guests or themes? 💡We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.Feel free to share in a private message or leave a comment below 🙏🏼(It's also ok to invite yourself 😉)Join Our Life Science Talent EcosystemWe want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

In this episode of Life Science Talent Talks, Søren welcomes Svend Petersen and Niels Bjerg Jensen, the pioneering co-founders of Mycoverse, to explore the entrepreneurial journey of building a life science startup that bridges cutting-edge biotechnology and sustainable agriculture.Mycoverse is at the forefront of innovation, leveraging high-throughput screening technology to develop natural solutions for fungal disease control — tackling one of the most pressing challenges in global food security while ensuring environmental safety. But transforming a scientific breakthrough into a viable commercial venture is no small feat.In this conversation, Svend and Niels share the origin story of Mycoverse, tracing their journey from identifying a critical gap in the market to securing exclusive technology licenses and assembling a team dedicated to reshaping the agricultural landscape. They discuss the defining moments that drove them to build this company, the biggest challenges they’ve faced—including regulatory hurdles, investor skepticism, and early-stage pivots — and the strategies they’ve used to navigate these complexities.Svend and Niels reflect on the personal lessons learned throughout their entrepreneurial journey — the resilience, adaptability, and vision required to drive innovation in the life sciences sector. They’ll also share their outlook on the future of Mycoverse, from immediate priorities to long-term goals, and offer insights for aspiring founders navigating similar challenges in this space.If you’re passionate about the intersection of science, entrepreneurship, and the future of sustainable agriculture, this episode is packed with valuable takeaways on what it really takes to turn groundbreaking research into a thriving startup.Stay tuned for an inspiring and in-depth conversation with the minds behind Mycoverse, right here on Life Science Talent Talks.Timestamps:00:39 Introduction to Mycoverse and Its Founders02:04 Mycoverse's Mission and Technology03:51 The Entrepreneurial Journey05:01 The Birth of Mycoverse08:09 Challenges and Milestones12:46 Business Model and Future Plans17:06 Funding and Investor Relations18:46 Market Opportunities and Unique Positioning19:45 Biologicals Discovery Platform: High-Throughput Screening on Filamentous Fungi20:09 Regulatory Approval and Market Strategy21:09 Non-GMO and EU Market Considerations22:14 Partnerships and Customer Dialogues25:31 Investor Concerns and Speed to Market29:45 Proud Moments and Team Dynamics33:39 Future Plans and ChallengesIdeas for future podcast guests or themes? 💡We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.Feel free to share in a private message or leave a comment below 🙏🏼(It's also ok to invite yourself 😉)Join Our Life Science Talent EcosystemWe want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

In this episode of Life Science Talent Talks, Nehar explores the development of a dynamic life science talent community. They are joined by Pia Petersen and Ulrik Gade, who share their expertise on agile methodologies, flow-based leadership, and organizational psychology.  The discussion delves into their professional journeys, the founding of Agil Procesforbedring, and the challenges they have navigated. A key focus is how leadership and self-organization can foster innovation and efficiency within life science organizations. The conversation highlights the importance of transparency, trust, and continuous improvement in building engaged, high-performing teams. Throughout the episode, Pia and Ulrik offer practical insights and real-world examples of effective management practices applicable to both startups and large enterprises. The episode concludes with book recommendations and actionable advice for life science professionals looking to enhance leadership and organizational effectiveness.Timestamps:00:59 Introduction to Our Guest: Pia Petersen02:06 Ulrik Gade Journey into Agile and Leadership04:02 Founding Agil Procesforbedring07:57 Challenges and Focus of the Company09:55 Leadership and Self-Organization17:37 Measuring the Value of Facilitation21:14 Continuous Improvement and Action Learning23:51 The Conscious Leader's Dilemma24:35 Stop Starting, Start Finishing28:19 The Importance of Transparency30:53 Engagement and Strategy in the Workplace33:44 Self-Organization and Task Management35:24 Operational and Strategic Contexts38:15 Challenges and Excitements in Leadership43:03 Final Thoughts and TakeawaysIdeas for future podcast guests or themes? 💡We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.Feel free to share in a private message or leave a comment below 🙏🏼(It's also ok to invite yourself 😉)Join Our Life Science Talent EcosystemWe want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

In this episode Dortea Engelund, COO and Co-founder of Devote Consulting, explores her journey of scaling a life sciences consultancy from a bold startup to a thriving organization. Dortea shares key insights into how Devote grew from 2 to 80 employees in just six years while maintaining a strong organizational culture and delivering exceptional value to the biotech and life sciences sector.This conversation dives into the strategies behind effective recruitment and the art of aligning new talent with company values to foster a cohesive and productive team. Dortea reflects on her personal leadership evolution, offering candid advice on navigating the challenges of delegation, adaptability, and decision-making in a rapidly growing business.Tune in to uncover the secrets behind building a thriving consultancy while staying true to your mission and values.Timestamps:00:38 Meet Dorothea: From Pharmacist to CEO02:11 Devote Consulting: Mission and Services05:48 Challenges and Successes in Scaling Devote08:01 Recruitment Strategies and Company Culture26:34 Customer-Centric Consulting Approach27:09 Building a Healthy Company Culture27:35 Trust and Integrity in Client Relationships29:33 Formalizing Cultural Values33:07 Employee Involvement and Idea Sharing35:53 Leadership and Role Evolution41:23 Delegation and Responsibility48:09 Challenges and Future DirectionsIdeas for future podcast guests or themes? 💡We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.Feel free to share in a private message or leave a comment below 🙏🏼(It's also ok to invite yourself 😉)Join Our Life Science Talent EcosystemWe want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

In this episode, Jes Andersen, a visionary leader and driving force behind the Innovation District Copenhagen, shares his expertise and insights on the hub's remarkable development and success. With a unique blend of academic, industry, and startup collaboration, the district has emerged as a global innovation hotspot. Jes talks about the origins and growth of the Innovation District, highlighting the pivotal role of strategic partnerships, infrastructure projects, and targeted lobbying efforts. Throughout the conversation, Jes emphasizes the importance of fostering a culture of collaboration, mutual respect, and open communication among diverse stakeholders. He discusses the district's evolution, from its humble beginnings to its current status as a thriving ecosystem, and shares valuable lessons learned along the way. Jes also reflects on his personal journey, revealing the passions and motivations that led him to spearhead this groundbreaking initiative. As a seasoned expert, Jes offers actionable advice for professionals seeking to contribute to and benefit from Copenhagen's vibrant innovation landscape. He emphasizes the need for adaptability, creativity, and resilience in navigating the complex intersections of academia, industry, and entrepreneurship. Additionally, Jes highlights the district's commitment to talent development, diversity, and inclusion, ensuring a dynamic and sustainable innovation ecosystem. Timestamps: Introduction and Overview (00:00 - 03:50) 00:32 - Overview of the Innovation District District Development (03:50 - 11:14) 03:50 - Rebranding and Development Strategies 08:29 - Fostering Collaborations and Partnerships Ecosystem Support (11:14 - 21:03) 11:14 - Government Support and Advocacy Efforts 15:04 - Quantum Computing and Emerging Trends 16:52 - Startup Support and Impact Assessment Vision and Leadership (21:03 - 34:32) 21:03 - Copenhagen's Attractiveness and Vision 31:25 - Jes Andersen's Personal Journey and Career Path 34:32 - Conclusion and Final Remarks Ideas for future podcast guests or themes? 💡 We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes. Feel free to share in a private message or leave a comment below 🙏🏼 (It's also ok to invite yourself 😉) Join Our Life Science Talent Ecosystem We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

Excited to share the latest episode featuring Line Holst Graves, CEO of Longest Straw, where she shares her inspiring journey from a corporate career to founding her own consultancy, which focuses on guiding biotech and planetary health founders through commercial expansion to secure high-value customers and strategic partnerships. Line discusses the common challenges scientific entrepreneurs face when commercializing their innovations, offering actionable advice for accelerating market validation. Key discussion points include the importance of building a strong commercial foundation, adopting a structured approach to client engagement, and leveraging external expertise to fuel business growth. Timestamps: 00:47 Line's Background and Career Journey 01:45 Starting the Longest Straw 05:10 Challenges and Support in Entrepreneurship 10:07 Advice for Aspiring Entrepreneurs 18:44 Common Gaps in Scientific Startups 20:24 Bridging the Commercial Experience Gap 20:56 Balancing Multiple Roles as a Founder 22:17 The Importance of Market Validation 24:34 Structured Approach to Client Engagement 25:45 The Value of Commercial Leadership 28:16 Practical Tips for Accelerating Market Validation 36:30 Looking Ahead: Future Plans and Opportunities 39:55 Final Advice for Founders Resource Mentioned: Line's email: line@longestdraw.com Ideas for future podcast guests or themes? 💡 We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes. Feel free to share in a private message or leave a comment below 🙏🏼 (It's also ok to invite yourself 😉) Join Our Life Science Talent Ecosystem We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

In the latest episode of Life Science Talent Talks, our host sits down with Jan Dideriksen, CEO and Founder of Nordic Virtual Pastures, to explore the company's fascinating journey. Jan shares how his team has navigated pivotal shifts in strategy and embraced an innovative approach by utilizing fractional hires to extend runway and optimize progress. A key focus of the discussion is Nordic Virtual Pastures' unique use of sustainably sourced cell media products from bio-waste streams to support cellular agriculture, cultivated meat, and mammalian cell growth. Jan shares insights on the importance of customer feedback, the company's strategic pivots and the role of fractional hires such as CCO Line Holst Graves in achieving milestones more efficiently. The conversation provides practical tips for startups on navigating pivots, engaging with investors, and leveraging fractional talent to achieve business goals. For startup leaders, investors, and innovators, this conversation is packed with actionable advice on managing pivots, engaging with investors, and building lean yet highly effective teams. Timestamps: 01:05 Overview of Nordic Virtual Pastures 01:12 Product Details and Technology 03:11 Market and Competitive Advantage 05:44 Journey to Entrepreneurship 07:25 First Pivot: From Cell Growth to Cultivated Meat 10:15 Second Pivot: Focusing on Media Components 13:20 Current Strategy and Market Fit 16:32 Feedback and Adaptation 20:43 Innovative Strategies for Product Market Fit 21:03 The Role of a Chief Commercial Officer 22:45 Importance of Customer Feedback 25:26 Fractional Hiring: A Strategic Approach 25:50 Building and Evolving the Team 32:58 Challenges and Benefits of Fractional Hiring 38:44 Future Plans and How to Support 39:50 Final Thoughts and Invitation to Connect Ideas for future podcast guests or themes? 💡 We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes. Feel free to share in a private message or leave a comment below 🙏🏼 (It's also ok to invite yourself 😉) Join Our Life Science Talent Ecosystem We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

In this insightful discussion, Cecilie Willer, whos executive coach specializing and founder mental health expert, shares her journey and professional expertise. The conversation dives into the psychological challenges faced by startup founders, including emotional regulation, identity fusion with their work, and active recovery.  Cecilie provides practical tools and techniques for founders to manage stress, enhance self-awareness, and maintain a sustainable work-life balance. She emphasizes the importance of mental health in building successful and sustainable companies. She also discusses her upcoming book, "Built Without Burnout" which offers concrete tools and insights for founders and investors to support mental health in the startup world. Timestamps: 02:06 Cecilia's Journey to Focusing on Founders' Mental Health 05:54 The Importance of Mental Health for Founders 07:25 Writing 'Built Without Burnout' 08:43 Challenges and Solutions for Founders' Mental Health 14:49 Self-Awareness and Emotional Regulation 25:00 Balancing Life and Startup Demands 29:11 Balancing Personal Life and Startup Growth 29:48 The Importance of Recovery for Founders 30:38 The Science Behind Burnout and Recovery 31:18 Implementing a Four-Day Work Week 32:22 Practicing Presence and Mindfulness 36:49 Dealing with Feelings of Inadequacy 44:48 Practical Tools for Self-Compassion 49:02 Conclusion and Resources Ideas for future podcast guests or themes? 💡 We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes. Feel free to share in a private message or leave a comment below 🙏🏼 (It's also ok to invite yourself 😉) Join Our Life Science Talent Ecosystem We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach Resource Mentioned In the episode: Changetoday.io Founder Tools

In this episode, Jacob Heckscher Sorensen, Director of Scientific Sales and Imaging Innovation at Gubra. Gubra, a biotech firm, specializes in clinical contract research organization services and proprietary drug discovery programs. Jacob delves into his career trajectory, from his educational background in developmental biology at Roskilde University and the University of Edinburgh to his groundbreaking work at Novo Nordisk and the Broad Institute. He shares insights on the development and application of quantitative 3D imaging and spatial biology in preclinical drug development. Jacob discusses the challenges and innovations in imaging, including the use of AI, automating microscopy processes, and the importance of building a virtual brain map for studying diseases like obesity, Alzheimer's, and Parkinson's. The conversation highlights the evolving technology's potential impact on future pharmaceutical and biotech research, emphasizing the synergy between scientific passion and business development in advancing the field. Timestamps: 00:51 Jacob's Academic Journey and Early Career 02:27 Transition to Novo Nordisk and Imaging Innovations 04:10 Current Role at Gubra and Imaging Applications 06:34 Innovative Applications in Quantitative 3D Imaging 08:48 Challenges and Future Directions in Imaging 12:00 The Role of Imaging in Preclinical Drug Development 12:30 Transition from Science to Sales 13:42 Daily Activities and Collaborations 16:37 Future of Neuroscience and Imaging 18:40 Challenges in the Life Science Industry 26:55 Final Thoughts and Advice for Young Scientists Ideas for future podcast guests or themes? 💡 We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes. Feel free to share in a private message or leave a comment below 🙏🏼 (It's also ok to invite yourself 😉) Join Our Life Science Talent Ecosystem We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach Resource Mentioned In the episode: Novo Nordisk Foundation Bioinnovation Institute (BII) Venture Lab & Venture House University of Copenhagen https://www.triptobio.com

In this episode of Life Science Talent Talks, we sit down with Line Kloster Pedersen, CEO and founder of  Visibuilt. Line shares the inspiring story behind Visibuilt’s founding — from the spark of an idea during a run to securing funding and building a lab. She also dives into the challenges of scaling from 0 to 10 employees and how her team is working toward transforming the global asphalt industry. Looking ahead, Visibuilt is targeting a soft launch in 2026, with a fully commercial product by 2028. This episode is packed with insights for entrepreneurs, including funding strategies, the importance of timing, and the realities of scaling a life sciences startup. This episode is packed with valuable insights for entrepreneurs, including how to navigate funding challenges, the importance of timing in startups, and the realities of scaling a life sciences company. Whether you're an aspiring founder or a seasoned entrepreneur, Line's story offers inspiration and practical takeaways. Timestamps: 00:05:09 - The Dirty Process of Asphalt Production 00:05:20 - Visibit's Innovative Solution 00:05:57 - Early Prototypes and Laboratory Phase 00:08:09 - Securing Early Funding and Building a Lab 00:10:26 - First Funding Successes 00:11:24 - Growth and Hiring the First Employees 00:12:35 - Building the Team and Securing Patents 00:16:07 - Future Goals and Commercialization Timeline 00:20:59 - Transitioning from Solo Founder to Team Leader 00:24:04 - Balancing Collective Perspective and Speed 00:25:08 - Deciding on Personal vs. Delegated Tasks 00:26:10 - One-on-One Meetings and Their Benefits 00:28:09 - Avoiding Problems Through Regular Check-ins 00:29:48 - Organizational Leadership Challenges 00:34:08 - Team Building Activities 00:36:25 - Hiring Strategies and Learnings 00:38:10 - Balancing Hires and Consultants 00:41:35 - Facility and Location Importance 00:43:11 - Most Rewarding Aspects of the Journey Ideas for future podcast guests or themes? 💡 We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes. Feel free to share in a private message or leave a comment below 🙏🏼 (It's also ok to invite yourself 😉) Join Our Life Science Talent Ecosystem We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Warm Regards from your podcast hosts:  Nehar Mortuza and Søren Spanner Bach